The study by Gupta et al. revealed that CREB1 and HINFP are essential TFs participating in the crosstalk between AD and Parkinson’s disease, suggesting that targeting CREB1 and HINFP could be potential common therapeutic targets for both AD and PD [76]. This evidence concerns the gene CREB1 and Alzheimer disease.